Offer - Urjas Oil for just ₹ 1 X
Caberlact, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Acromegaly, Prolactinoma.
The optimal dosage of Caberlact is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Caberlact side effects, there are can be others also. These have been listed below. Usually, these side effects of Caberlact go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Caberlact's effect during pregnancy is Mild and Severe while nursing. It is important to know if Caberlact has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Caberlact related warnings section.
Caberlact can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Caberlact in conditions like High Blood Pressure, Heart Disease, Depression. Other contraindications of Caberlact have been discussed in the sections ahead.
Drug interactions for Caberlact have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Caberlact is not safe while driving, and is is not addictive in nature.
Caberlact is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Caberlact safe for pregnant women?
Caberlact rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Caberlact safe during breastfeeding?
Caberlact may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Caberlact on the Kidneys?
Kidney can be affected by Caberlact. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Caberlact on the Liver?
You may experience side effects on your liver after taking Caberlact. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Caberlact on the Heart?
You may experience side effects on your heart after taking Caberlact. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Caberlact should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Caberlact unless your doctor advises you to do so -
Is this Caberlact habit forming or addictive?
No, there is no any evidence that Caberlact is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Caberlact. So it is best to avoid driving.
Is it safe?
Yes, Caberlact is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Caberlact is unable to treat or cure mental disorders.
Interaction between Food and Caberlact
Due to the absence of research, it is difficult to say how Caberlact and food will interact.
Interaction between Alcohol and Caberlact
Taking Caberlact and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)